Clinical trial
Electroacupuncture to Prevent Chemotherapy-Related Cognitive Impairment in Patients With Breast Cancer
NCT05941598 is registered in ClinicalTrials.gov with Beijing University of Chinese Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Electroacupuncture to Prevent Chemotherapy-Related Cognitive Impairment in Patients With Breast Cancer
- Lead sponsor
- Beijing University of Chinese Medicine
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 1, 2023
- Completion date
- December 30, 2024
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.